MediView XR has closed a $24 million Series A funding round to accelerate the commercialization of its augmented reality surgical navigation platform. The Cleveland-based medtech company secured investment from GE HealthCare, which led the round, along with Cleveland Clinic, Mayo Clinic, Edge Ventures (the investment arm of Emplify Health), and JobsOhio Growth Capital Fund.
The financing brings together some of healthcare's most respected institutions and validates MediView's approach to addressing long-standing challenges in medical imaging. Founded on intellectual property developed at Cleveland Clinic, the company has built an FDA-cleared platform that fundamentally changes how clinicians interact with patient data during procedures.
Most medical procedures today still rely on physicians mentally translating flat, two-dimensional images into three-dimensional understanding. Doctors constantly look away from patients to check monitors, breaking their natural hand-eye coordination and adding cognitive strain during already demanding interventions.
MediView's platform addresses this by projecting 3D patient anatomy directly through the skin, visible in real time during procedures. The system fuses CT scans with live ultrasound imaging, creating an interactive overlay that shows organs, blood vessels, tumors, and other target anatomy in their actual spatial context. Clinicians can see exactly where they're working without looking away from the patient.
"Our mission is to simplify, democratize, and inform medical procedures by giving clinicians intuitive, real-time 3D visualization and guidance tools to aid in their clinical decision making," said Mina Fahim, MediView CEO. "We are redefining how to understand and navigate the relationship between interventional tools and target anatomy making less invasive procedures more predictable and accessible. Our partnership and collaboration with GE HealthCare, Cleveland Clinic, Mayo Clinic and Emplify Health accelerates our ability to expand clinical and commercial adoption of our innovative solutions towards improving outcomes, enhancing safety, and creating a new standard in interventional care."
The technology provides what the company describes as a "head-up, hands-free 3D experience." Doctors can target small lesions more accurately, maintain better ergonomics, and even collaborate remotely with colleagues through shared visualization tools. For procedures like biopsies, tumor ablations, and targeted injections, the platform offers precision that traditional imaging methods struggle to match.
MediView plans to use the capital across five main areas. The company will scale commercial and clinical adoption of its AR solutions at healthcare institutions. It will also pursue partnerships with medical imaging companies, therapeutic device makers, and technology providers to drive broader market adoption.
Clinical validation remains a priority. MediView intends to advance publications and regulatory approvals that demonstrate clinical, workflow, and economic benefits. Product development will continue across surgical visualization, navigation, data analytics, and remote collaboration features, with plans to expand into multiple clinical specialties. Finally, the company will grow its operational infrastructure to meet rising demand from hospitals worldwide.
MediView launched based on technology originally developed at Cleveland Clinic, one of the country's leading academic medical centers. The company is based in Cleveland, Ohio, where it has built a comprehensive augmented reality platform designed to make 3D medical data more useful in clinical settings.
The platform targets a specific problem: making minimally invasive procedures more accessible and predictable. By providing intuitive visualization tools, MediView aims to reduce the technical barriers that sometimes limit which procedures can be performed and by whom. The goal is to expand access to less invasive care while maintaining or improving procedural outcomes.
The company's technology has already earned FDA clearance, a significant regulatory milestone that allows it to be marketed and used in U.S. healthcare facilities.
The investor group includes some of the most influential names in healthcare and medical technology. GE HealthCare, which led the round, brings deep expertise in medical imaging and a vast global distribution network. Cleveland Clinic and Mayo Clinic, two of the world's premier healthcare systems, add clinical credibility and institutional support.
Edge Ventures, the investment vehicle of Emplify Health, and JobsOhio Growth Capital Fund round out the syndicate. Their participation signals confidence in both MediView's technology and its business potential.
"Our collaboration with MediView reflects a shared commitment to integrating advanced imaging with intuitive augmented reality technologies that have the potential to transform precision care," said Meraj Khan, Chief Marketing Officer, Surgical Innovations, Advanced Visualization Solutions, GE HealthCare. "We're proud to help lead this funding round and redefine how clinicians visualize anatomy in real-time to enhance procedural guidance and navigation."
The medical industry is watching closely as artificial intelligence and augmented reality begin to intersect in clinical settings. AI can handle time-intensive tasks like image processing and preoperative planning, while AR provides intuitive interfaces for doctors to interact with that processed data.
Together, these technologies promise to streamline workflows that currently consume significant physician time and attention. MediView's platform sits at this convergence, using AI-processed imaging data and presenting it through AR interfaces that doctors can manipulate in real time. As both technologies mature, their combined impact on surgical efficiency and precision could be substantial.
